Cancer stem cell (CSC) theory has been proposed and verified in many cancers. The existence of osteosarcoma CSCs has been confirmed for many years and multiple surface markers have been employed to identify them. In this study, we identified CD271(+) subpopulation of osteosarcoma displaying stem-like properties. CD271, known as the neural crest nerve growth factor receptor, is the marker of bone marrow mesenchymal stem cells (MSCs) and human melanoma-initiating cells. We discovered that CD271 was expressed differentially in diverse types of human osteosarcoma and stabilized cell lines. CD271(+) osteosarcoma cells displayed most of the properties of CSC, such as self-renewal, differentiation, drug resistance and tumorigenicity in vivo. Nanog...
The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the las...
Cancer stem cells that display tumor-initiating properties have recently been identified in several ...
Bone sarcomas are a clinically and molecularly heterogeneous group of malignancies characterized by ...
Background: Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity be...
Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity between indivi...
<div><p>Background</p><p>Large-scale genomic analyses of patient cohorts have revealed extensive het...
The cancer stem cell theory suggest that presence of small subpopulation of cancer stem cells are th...
BACKGROUND: Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity be...
Osteosarcomas (OSs) are a heterogeneous group of rare tumors that affect children and adolescents be...
Cancer stem cells that display tumor-initiating properties have recently been identified in several ...
The Low-Affinity Nerve Growth Factor Receptor (LNGFR), also known as CD271, is a member of the tumor...
Cancer stem cells contribute to the malignant phenotypes of a variety of cancers, but markers to ide...
The question whether tumorigenic cancer stem cells exist in human melanomas has arisen recently1. He...
Cancer stem cells contribute to the malignant phenotypes of a variety of cancers, but markers to ide...
Sarcomas are a large family of cancers originating in the mesenchyme. Composed of more than 100 hist...
The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the las...
Cancer stem cells that display tumor-initiating properties have recently been identified in several ...
Bone sarcomas are a clinically and molecularly heterogeneous group of malignancies characterized by ...
Background: Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity be...
Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity between indivi...
<div><p>Background</p><p>Large-scale genomic analyses of patient cohorts have revealed extensive het...
The cancer stem cell theory suggest that presence of small subpopulation of cancer stem cells are th...
BACKGROUND: Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity be...
Osteosarcomas (OSs) are a heterogeneous group of rare tumors that affect children and adolescents be...
Cancer stem cells that display tumor-initiating properties have recently been identified in several ...
The Low-Affinity Nerve Growth Factor Receptor (LNGFR), also known as CD271, is a member of the tumor...
Cancer stem cells contribute to the malignant phenotypes of a variety of cancers, but markers to ide...
The question whether tumorigenic cancer stem cells exist in human melanomas has arisen recently1. He...
Cancer stem cells contribute to the malignant phenotypes of a variety of cancers, but markers to ide...
Sarcomas are a large family of cancers originating in the mesenchyme. Composed of more than 100 hist...
The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the las...
Cancer stem cells that display tumor-initiating properties have recently been identified in several ...
Bone sarcomas are a clinically and molecularly heterogeneous group of malignancies characterized by ...